Physician
Shoals Pediatric Group PC
Shoals Pediatric Group PC was paid $4.44M by Medicaid between Jan 2018 and Dec 2024, across 48 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 38% of everything it billed.
33Billing provider infoSHOALS PEDIATRIC GROUP PC
FLORENCE, AL 35630
FLORENCE, AL 35630
33aNPI1609971647assigned 09/14/2006
33bProvider typePediatrics Physician
28Total paid$4.44M
24GClaims114,242
24DCodes billed48
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Alabama
Rank by total paid#39 of 199
Median peer was paid$702K
This provider vs. median6.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,539 | $533K | |
| 2019 | 17,945 | $657K | |
| 2020 | 12,297 | $456K | |
| 2021 | 17,720 | $636K | |
| 2022 | 20,514 | $807K | |
| 2023 | 17,799 | $704K | |
| 2024incomplete | 13,428 | $650K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 38% | 42,004 | 36,145 | $1.68M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 36% | 18,616 | 16,367 | $1.58M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 4.2% | 3,065 | 2,827 | $188K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.8% | 2,779 | 2,577 | $168K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.2% | 2,179 | 1,956 | $141K |
| 87430 | 2.9% | 12,854 | 12,040 | $130K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.7% | 11,926 | 5,616 | $121K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.4% | 1,802 | 1,685 | $108K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 2.1% | 4,131 | 3,849 | $93K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 753 | 691 | $39K |
| 90670 | <1% | 1,376 | 1,302 | $25K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 209 | 203 | $19K |
36 more codes
| 90686 | <1% | 981 | $18K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,216 | $13K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,542 | $11K |
| 90461 | <1% | 233 | $10K | |
| 90723 | <1% | 544 | $10K | |
| 90647 | <1% | 475 | $9K | |
| 87807 | <1% | 872 | $9K | |
| 90680 | <1% | 420 | $8K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 228 | $5K |
| 90734 | <1% | 208 | $5K | |
| 90651 | <1% | 144 | $5K | |
| 92081 | <1% | 227 | $5K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 728 | $4K |
| 90633 | <1% | 192 | $4K | |
| 90672 | <1% | 174 | $3K | |
| 99001 | <1% | 1,223 | $3K | |
| 90648 | <1% | 180 | $3K | |
| 99051 | <1% | 156 | $3K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,796 | $3K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 21 | $2K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 72 | $2K |
| 90671 | <1% | 66 | $1K | |
| 92551 | <1% | 109 | $1K | |
| 90710 | <1% | 66 | $1K | |
| 90696 | <1% | 66 | $1K | |
| 90677 | <1% | 59 | $1K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 81 | $814.26 |
| 90715 | <1% | 39 | $732.23 | |
| 71045 | Radiologic examination, chest; single view | <1% | 40 | $469.34 |
| 81003 | <1% | 148 | $317.40 | |
| 90619 | <1% | 16 | $316.64 | |
| 90656 | <1% | 14 | $277.06 | |
| 90700 | <1% | 13 | $237.48 | |
| 99177 | <1% | 175 | $175.12 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 12 | $120.00 |
| 99000 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMARKS, GLENDA (OFFICE MANAGER)